Psoriasis: Clinical Trials

11 trials for Psoriasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 terminated. 11 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 411Terminated 11

Follow Psoriasis: new trials by email Literature Review of Psoriasis trials Research Report on Psoriasis

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Deucravacitinib for the Treatment of Palmoplantar Pustulosis
Deucravacitinib - Palmoplantar Pustulosis
Phase 4TerminatedBrigham and Women's Hospital32023-07-012026-04-07
Effect of Guselkumab on Cardiovascular Risk Surrogate Markers in Participants With Moderate to Severe Plaque Psoriasis
Guselkumab - Psoriasis
Phase 4TerminatedJanssen-Cilag Ltd.152021-11-232025-03-30
Dose Tapering Study of Adalimumab in Psoriasis
Venapuncture, Dried blood spot, Dose reduction - Psoriasis Vulgaris
Phase 4TerminatedUniversity Hospital, Ghent192021-02-162024-09-19
Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to Ustekinumab
Brodalumab, Placebo, Guselkumab - Plaque Psoriasis, Psoriasis Vulgaris
Phase 4TerminatedLEO Pharma1132020-12-172025-03-14
Multicenter Randomized Double Blind Controlled-study to Assess the Potential of Methotrexate Versus Placebo to Improve and Maintain Response to Anti TNF- Alpha Agents in Adult Patients With Moderate to Severe Psoriasis
Methotrexate, Methotrexate Placebo - Psoriasis
Phase 4TerminatedAssistance Publique Hopitaux De Marseille782017-01-232025-11-20
Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy
Varicella Zoster Vaccine, Placebo - Psoriasis
Phase 4TerminatedInnovaderm Research Inc.32016-06-012017-07-02
Addition of Excimer Laser to Treatment With Acitretin Tablets for Psoriasis of the Palms and Soles
Excimer laser, Acitretin - Psoriasis, Skin or Nails
Phase 4TerminatedIcahn School of Medicine at Mount Sinai22014-06-012021-03-10
Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab
Etanercept - Psoriasis
Phase 4TerminatedAmgen642012-02-012017-12-29
Determination of the Efficacy and Safety of Psoralait Versus Placebo in the Treatment of Psoriasis
Psoralait, Placebo cream. - Psoriasis
Phase 4TerminatedTrima, Israel Pharmaceutical Products152011-01-012014-12-17
Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis
Taclonex Ointment and Hydrogel Patch, Taclonex Ointment - Plaque Psoriasis, Psoriasis Vulgaris
Phase 4TerminatedUniversity of California, San Francisco352009-06-012019-04-18
Effects of Capsaicin on the Structure, Distribution, and Function of Cutaneous Small Nerve Fibers in Psoriatic Skin
Capsaicin - Psoriasis
Phase 4TerminatedWake Forest University122006-06-012018-08-13

Narrower conditions

Herpes Zoster (1)  ·  Rhabdomyosarcoma, Alveolar (1)

Broader conditions

Skin Diseases (11)  ·  Skin Diseases, Papulosquamous (11)  ·  Skin and Connective Tissue Diseases (11)  ·  DNA Virus Infections (1)  ·  Herpesviridae Infections (1)  ·  Infections (1)  ·  Myosarcoma (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Connective and Soft Tissue (1)  ·  Neoplasms, Muscle Tissue (1)  ·  Rhabdomyosarcoma (1)  ·  Sarcoma (1)  ·  Varicella Zoster Virus Infection (1)  ·  Virus Diseases (1)

Interventions

guselkumab (2)  ·  Acitretin (1)  ·  Capsaicin (1)  ·  Dried Blood Spot Testing (1)  ·  Drug Tapering (1)  ·  Etanercept (1)  ·  Herpes Zoster Vaccine (1)  ·  Laser Therapy (1)  ·  Lasers, Excimer (1)  ·  Methotrexate (1)  ·  Sodium Chloride (1)  ·  brodalumab (1)  ·  deucravacitinib (1)

Sponsors

Amgen (1)  ·  Assistance Publique Hopitaux De Marseille (1)  ·  Brigham and Women's Hospital (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  Innovaderm Research Inc. (1)  ·  Janssen-Cilag Ltd. (1)  ·  LEO Pharma (1)  ·  Trima, Israel Pharmaceutical Products (1)  ·  University Hospital, Ghent (1)  ·  University of California, San Francisco (1)  ·  Wake Forest University (1)

Countries

United States (5)  ·  Belgium (2)  ·  Canada (2)  ·  France (2)  ·  Germany (2)  ·  Greece (2)  ·  Italy (2)  ·  Austria (1)  ·  Denmark (1)  ·  Israel (1)  ·  Netherlands (1)  ·  Spain (1)  ·  Sweden (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Gil Yosipovitch, MD (1)  ·  Jo Lambert, Prof, dr (1)  ·  John Koo, MD (1)  ·  Lyn Guenther, MD, FRCPC (1)  ·  Mark Lebwohl, MD (1)

Results publications

PMID 35683398, PMID 38300408

NIH funding

2015 (1), 2019 (1)